Kidney Health Initiative (KHI)

KHI Mission

Kidney Health Initiative

To advance scientific understanding of the kidney health and patient safety implications of new and existing medical products and to foster development of therapies for diseases that affect the kidney by creating a collaborative environment in which FDA and the greater nephrology community can interact to optimize evaluation of drugs, devices, biologics, and food products.

Call for Nominations for KHI Board of Directors

The KHI Board of Directors is looking for individuals interested in serving on the Board of Directors. Terms are 3 years starting in January 2018. Application Deadline is Tuesday, August 15. To learn more about the Board of Directors' Call for Nomination or the nomination process, click here.

KHI Annual Report 2016

On behalf of the Board of Directors, we would like to thank the KHI membership for their participation in KHI, which has seen its membership grow from 47 organizations in September 2013, to more than 75 organizations in December 2016. The membership has worked diligently through KHI to improve patient safety and promote the development of optimal therapies for diseases that affect kidneys and the quality of life for millions of people.

View KHI's 2016 Annual Report.

View KHI's 2015 Annual Report.

View the KHI Inaugural Review 2012-2014.

Open Call for Workgroups

The following is a list of current opportunities for KHI members to volunteer their service on a project workgroup. Click on the title for more information and details on how to volunteer.

Involvement in workgroups is on a voluntary basis with no compensation provided. All workgroup members are required to submit an online disclosure form with their application.

KHI Publications

Learn More

If you have any questions about KHI, or would like more information about becoming a member, please contact khi@asn-online.org.